- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Epigenetic Modulation for the Treatment of Sarcoma
Authors
Keywords
Sarcoma, Ewing sarcoma, Epigenetics, HDAC inhibitor, EZH2, Chromatin modification
Journal
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 14, Issue 3, Pages 454-464
Publisher
Springer Nature
Online
2013-06-07
DOI
10.1007/s11864-013-0239-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma
- (2013) Cigall Kadoch et al. CELL
- Epigenomics of cancer – emerging new concepts
- (2012) Melanie R. Hassler et al. BIOCHIMIE
- Deconstruction of the SS18-SSX Fusion Oncoprotein Complex: Insights into Disease Etiology and Therapeutics
- (2012) Le Su et al. CANCER CELL
- A Phase I Pharmacokinetic and Pharmacodynamic Study of CHR-3996, an Oral Class I Selective Histone Deacetylase Inhibitor in Refractory Solid Tumors
- (2012) U. Banerji et al. CLINICAL CANCER RESEARCH
- Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
- (2012) Yi-Che Changchien et al. Journal of Translational Medicine
- Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
- (2012) Penella J Woll et al. LANCET ONCOLOGY
- A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)
- (2012) Jodi A. Muscal et al. PEDIATRIC BLOOD & CANCER
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2
- (2011) Stefan Burdach et al. CELL CYCLE
- Keeping chromatin quiet
- (2011) Jacqueline E. Mermoud et al. CELL CYCLE
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Loss of SMARCB1/INI1 expression in poorly differentiated chordomas
- (2010) Bret C. Mobley et al. ACTA NEUROPATHOLOGICA
- Trends in survival for patients with metastatic soft-tissue sarcoma
- (2010) Antoine Italiano et al. CANCER
- Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells
- (2010) Cao Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin
- (2010) Luke A. Wittenburg et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Epigenetic Remodeling of Chromatin Architecture: Exploring Tumor Differentiation Therapies in Mesenchymal Stem Cells and Sarcomas
- (2010) Sara Siddiqi et al. Current Stem Cell Research & Therapy
- SMARCB1/INI1 Protein Expression in Round Cell Soft Tissue Sarcomas Associated With Chromosomal Translocations Involving EWS: A Special Reference to SMARCB1/INI1 Negative Variant Extraskeletal Myxoid Chondrosarcoma
- (2009) Kenichi Kohashi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Inhibitors of Deacetylases Suppress Oncogenic KIT Signaling, Acetylate HSP90, and Induce Apoptosis in Gastrointestinal Stromal Tumors
- (2009) T. Muhlenberg et al. CANCER RESEARCH
- Genomic Analysis Using High-Density Single Nucleotide Polymorphism-Based Oligonucleotide Arrays and Multiplex Ligation-Dependent Probe Amplification Provides a Comprehensive Analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors
- (2009) E. M. Jackson et al. CLINICAL CANCER RESEARCH
- An operational definition of epigenetics
- (2009) S. L. Berger et al. GENES & DEVELOPMENT
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
- (2009) G. H. S. Richter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma
- (2008) Vasilios Karavasilis et al. CANCER
- A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
- (2008) Nabeel Pervaiz et al. CANCER
- Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells
- (2008) Annie Hurtubise et al. Cancer Cell International
- EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
- (2008) N. Riggi et al. CANCER RESEARCH
- Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor
- (2008) Kenichi Kohashi et al. HUMAN PATHOLOGY
- Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models
- (2008) Shuzhen Liu et al. MOLECULAR CANCER THERAPEUTICS
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started